Evaluation of Rheumatoid Arthritis Disease Education Literature

Rheumatoid arthritis is an inflammatory disease that results in joint inflammation, pain and swelling. It may progress to advance stages that render patients unable to carry out their daily activities. It also results in joints deformity and is a leading cause of disability globally.

Patient education plays an important role in the management of disease. Adequate patient knowledge and awareness about disease may help in incorporating the ailment in daily life. The purpose of this study is to evaluate the benefit of a disease education literature in Urdu language and with culturally relevant illustration for rheumatoid arthritis patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rheumatoid Arthritis Arthritis Arthritis, Rheumatoid Autoimmune Diseases Behavior Connective Tissue Diseases Immune System Diseases Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clifton Central Hospital, Karachi, Sindh, Pakistan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Out-patients with established diagnosis of rheumatoid arthritis over 3 months.
Participants who are willing to participate in the study.

Exclusion criteria

Patients with no rheumatoid arthritis.
Patients currently undergoing surgery or had previous history of surgery.
Patients who are not willing to participate.
In-patients.

Treatment and study plan

Patient education

Behavioral

Rheumatoid arthritis patients will be provided with disease education literature

Primary outcomes

Patient knowledge about rheumatoid arthritis

Time frame: 3 months

Measurement of patient's knowledge and awareness about rheumatoid arthritis using The 13-item Rheumatoid Arthritis Knowledge Assessment Scale (RAKAS-13) before and after the intervention.

The RAKAS-13 is a psychometric tool consisting of 13 multiple choice questions related to rheumatoid arthritis disease knowledge. All questions have 1 point for "Right" answer and zero (0) points for "Wrong" answer.

The scoring criteria are as follows:

Excellent knowledge More than 75% correct answers = Above 11 points

Adequate knowledge More than 50% or equal to 75% correct answers = 8 - 10 points

Low knowledge More than 30% or equal to 50% correct answers = 5 - 7 points

Poor knowledge Less than 30% correct answers = 4 points or less.

Secondary outcomes

Patient satisfaction

Time frame: 3 months

Patient satisfaction with be documented after the educational intervention using a patient satisfaction feedback form. It contains 10 questions related to general satisfaction from the intervention

Sponsors and collaborators

Lead sponsor

Universiti Sains Malaysia

Other

Registry information

Official study title

Evaluation of Rheumatoid Arthritis Disease Education Literature: The ERADEL Trial

Acronym: ERADEL

Important dates

Study start: 2017
Primary completion: 2019
Study completion: 2019
First posted: Nov 8, 2017
Registry last updated: Mar 24, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed